INTRODUCTION
The concentration of dopamine in the synaptic and extrasynaptic space is controlled to a great extent by the action of dopamine transporters (DATs 1 ), which utilize the energy of Na + and Cl -ionic gradients to drive reuptake of the neurotransmitter into the presynaptic cell (1) . DAT belongs to a family of transporters including those for norepinephrine (NET) and serotonin (SERT) that constitutes the major sites of action for tricyclic antidepressants and psychostimulants (2) . Other neurotransmitter reuptake carriers include plasma membrane transporters for glycine (Glyt1) and γ-aminobutyric acid (GAT1), and the synaptic vesicle monoamine and acetylcholine transporters, VMAT and VAChT (3, 4) . These proteins are believed to have a similar structure of twelve transmembrane-spanning domains, cytoplasmically oriented N-and C-termini, and numerous potential phosphorylation sites for various protein kinases.
Recent studies have shown that DATs and other neurotransmitter transporters are phosphoproteins whose functions are acutely regulated by protein kinases, providing a mechanism for temporal and spatial control of synaptic neurotransmitter levels and neural signaling (5) (6) (7) (8) (9) . Activators of protein kinase C (PKC) and inhibitors of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) cause an increase in DAT phosphorylation with a concomitant reduction in dopamine transport activity (5, 10, 11) . A common theme emerging from these studies is that phosphorylation and functional regulation of transporters are accompanied by changes in their cell surface density (6, 7, (12) (13) (14) . Phorbol esters stimulate clathrin-mediated endocytosis of DAT that results in intracellular sequestration and trafficking (12, 13) . However, it is not known if phosphorylation of DAT is required for these processes and/or contributes to other aspects of transport regulation or function.
Our current goal is to identify the sites of phosphorylation on DAT and elucidate their functional significance. The presumed intracellular aspects of rDAT contain numerous serines, threonines, and tyrosines, many of which are present in PKC, protein kinase A and Ca 2+ -calmodulin dependent protein kinase consensus motifs (Fig. 1 ). These residues are found in both N-and C-terminal cytoplasmic tails and in all intracellular loops (ILs) except IL1. The large number of potential phosphorylation sites, in conjunction with the possibility of multi-site phosphorylation, has made determination of phosphorylation sites by molecular approaches problematic. Attempts to identify sites contributing to regulation of DAT, GAT1 and Glyt1 using mutagenesis of PKC consensus motifs and/or sites highly conserved throughout the neurotransmitter transporter family have not been successful (14) (15) (16) , as phorbol ester-induced regulation was maintained after mutagenesis. It is possible that the sites examined were not those involved in phosphorylation, or that multiple sites are involved and mutagenesis of the examined sites was insufficient to produce a result.
In this study we used phosphoamino acid analysis and protease-based peptide mapping strategies to directly identify the region of DAT that undergoes phosphorylation in rat brain tissue. The results show that one or more serines at the extreme end of the N-terminal tail are the major sites of both basal and stimulated phosphorylation. These results have implications for the molecular basis of transport regulation and provide strong direction for mutagenesis approaches. 32 PO 4 was from ICN; okadaic acid (OA), 1-oleoyl-2-acetyl-snglycerol (OAG), and phorbol 12-myristate, 13-acetate (PMA) were from Calbiochem; endoproteinase asp-N was from Boehringer Mannheim; high and low range Rainbow molecular weight markers were from Amersham; phosphoamino acid standards, Aminopeptidase 1, Carboxypeptidase Y, and TPCK-treated trypsin were from Sigma; phosphopeptide standards were synthesized by Cell Essentials (Boston, MA); and tricine gel reagents were from BioRad.
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MATERIALS AND METHODS
Materials
Rats were purchased from Charles River Laboratories and were housed and treated in accordance with regulations established by the National Institutes of Health and the University of North Dakota Animal Care and Use Committee.
Metabolic Phosphorylation of DAT -For most experiments phosphorylated DATs were prepared from rat striatal slices metabolically labeled with 32 PO 4 using procedures adapted from Halpain et al. (17) . Male Sprague-Dawley rats (175-300 g) were decapitated and the striata were rapidly removed and weighed. The tissue was sliced into 350 µm slices using a McElvain Tissue Chopper and equivalent amounts of tissue (4-8 slices) were placed into wells of a 12-well culture plate containing oxygenated Krebs-bicarbonate buffer consisting of 25 mM NaHCO 3 , 125 mM NaCl, 5 mM KCl, 1.5 mM CaCl 2 , 5 mM MgSO 4 , and 10 mM glucose, pH 7.3. Slices were preincubated for 30 min at 30ÚC, with shaking at 105 rpm, followed by exchange with fresh buffer containing 1 mCi/ml 32 PO 4 and continued incubation with shaking at 30°C for 90-6 . et al Foster 120 min. Oxygen (95% O 2 : 5% CO 2 ) was gently blown across the top of the plate during the incubation and test compounds or vehicle were added for the final 30 min. Test compounds (OA, OAG, and PMA) were dissolved at high concentrations in dimethyl sulfoxide (DMSO) followed by dilution in the incubation mixture to a final DMSO concentration of 0.1%. In all experiments control tissue received 0.1% DMSO, which by itself had no effect on the phosphorylation state of DAT. At the end of labeling, tissue slices were transferred to a microcentrifuge tube and centrifuged at 4ÚC at 800 x g for 4 minutes. The supernatant fractions were removed and 1 ml ice-cold Krebs-bicarbonate buffer was added to the slices. The tissue was disrupted by 4 passages through a 26 gauge needle, samples were centrifuged at 10,000 x g for 10 min at 4ÚC, and the supernatant fractions were removed from the sedimented membranes.
For in situ proteolysis procedures, membranes were resuspended in 50 mM Tris-HCl, pH 8.0, at 50 mg/ml original wet weight, and for immunoprecipitation and gel purification, membranes were solubilized with 0.5% SDS at 20 mg/ml original wet weight. For both procedures, aliquots were removed for protein assay using the Pierce protein assay kit with bovine serum albumin as the standard, and sample volumes were adjusted to equalize protein content. For one experiment phosphorylated DAT was prepared from rat striatal synaptosomes metabolically labeled with 32 PO 4 and treated with vehicle, PMA, or OA as previously described (5) . Briefly, synaptosomes suspended in KBB were labeled with 1 mCi/ml 32 PO 4 at 30 ÚC for 45 min with drug treatments given for the final 15 min. All phosphorylation and peptide mapping results were verified in 2 or more independent experiments. (18) and prepared for in situ proteolysis or gel purification in parallel with 32 PO 4 -labeled DATs. Immunoprecipitations of phosphorylated or photoaffinity-labeled samples were performed with rabbit polyclonal antisera 16 or 18 generated against N-terminal amino acids 42-59 (peptide16) or C-terminal amino acids 580-608 (peptide 18) of the rDAT protein sequence (18) . Samples were electrophoresed on SDS polyacrylamide gels and dried gels were subjected to autoradiography using Kodak Biomax film for 12-48 hours. The region of the gel containing DAT was excised for processing as described below, and in some experiments radioactivity in excised 32 PO 4 -labeled DAT samples was assessed by Cerenkov counting.
Photoaffinity Labeling and Immunoprecipitation
The identity of novel fragments immunoprecipitated with serum 16 was verified by inclusion of 50 µg/ml peptide 16 or peptide 1 (residues 6-21) during immunoprecipitation. High and low range Rainbow molecular weight markers were used as standards on all gels.
Phosphoamino Acid Analysis -Phosphoamino acid analysis was performed using the method of Boyle et al. (19) . 32 PO 4 -labeled striatal slices were treated with vehicle or test compounds, and membranes were solubilized, immunoprecipitated with antiserum 16, and electrophoresed on 8% gels. After drying and autoradiography, the region of the gel containing DAT was excised and protein was eluted overnight at 22ÚC in 0.1 M ammonium bicarbonate, pH 8.0. Samples were oxidized with performic acid followed by precipitation with trichloroacetic acid and hydrolysis for 2 h at 110ÚC with 5.7 M HCl. Unlabeled phosphoamino acid standards (p-ser, p-thr, and p-tyr) were dissolved in pH 1.9 buffer (acetic acid 7.8%, formic acid 2.5%) and added to the unknowns at 1 mg/ml. Samples were spotted onto cellulose 8 . et al Foster thin-layer plates and electrophoresed using a Hunter thin-layer electrophoresis unit at 1.5 kV for 35 minutes at pH 1.9 (acetic acid 7.8%, formic acid 2.5%) in the first dimension, and at 1.3 kV for 20 minutes at pH 3.5 (pyridine 0.5%, acetic acid 5%) in the second dimension. Standards were visualized with ninhydrin and the plates were subjected to autoradiography for 10-14 days.
In Situ Proteolysis and Immunoblotting -Striatal membrane suspensions labeled with 32 PO 4 were subjected to in situ proteolysis as previously described (18) followed by analysis of DAT by immunoprecipitation and western blotting. Briefly, membranes were treated with trypsin or endoproteinase asp-N for 10 or 60 min, respectively, at 22ÚC, sedimented by centrifugation, and the supernatants were transferred to fresh tubes. Membranes were solubilized and subjected to immunoprecipitation with antisera 16 or 18, followed by electrophoresis and autoradiography on 9% SDS-PAGE gels or 8-16% Tris-tricine gradient gels (20) . In some experiments, the supernatant fractions were also subjected to immunoprecipitation to assay for fragments released from membranes. For western blotting, trypsin-treated membranes were electrophoresed on 8% SDS-PAGE gels followed by electrophoretic transfer to 0.45 µm PVDF membranes. Dried membranes were blocked with 3% BSA prepared in 10 mM phosphate buffered saline (PBS), pH 7.4 for 1.5 h followed by 5% non-fat dry milk in 10 mM PBS, pH 7.4 for 0.5 h, washed extensively and probed with antiserum 16 diluted 1:100 in 3% BSA-10 mM PBS, 7.4. Blots were washed, then incubated for 1 h at room temperature with goat anti-rabbit IgG linked alkaline phosphatase diluted 1:5000 in a 3% BSA-10 mM PBS solution. After extensive washing, blots were developed colorimetrically using the alkaline phosphatase substrate 5-bromo-4-cholro-3-indolyl phosphate/nitro blue. Dried blots were scanned and quantitated with Molecular Analyst software (BioRad).
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Aminopeptidase and Carboxypeptidase Treatment -DATs from 32 PO 4 -labeled striatal synaptosomes or striatal slices were immunoprecipitated, gel purified on 8% SDS-PAGE gels and electroeluted as previously described (21) . Aliquots of the electroeluted samples were treated with 1-100 µg/ml of Aminopeptidase 1 or Carboxypeptidase Y prepared in 50 mM Tris HCl, pH 8.0, for 1h at 22ÚC, followed by addition of SDS-PAGE sample buffer and electrophoresis and autoradiography on 8% SDS-PAGE gels. In some experiments DATs labeled with [ 125 I]DEEP were treated and analyzed in parallel.
Phosphopeptide Analysis -Limit tryptic digestion and phosphopeptide analysis were performed using the method of Boyle et al. (19) . 32 PO 4 -labeled striatal slices were treated with 1 µM OA, and membranes were solubilized, immunoprecipitated with antiserum 16, and subjected to electrophoresis on 8% SDS-PAGE gels. After drying and autoradiography, the region of the gel containing DAT was excised and protein was eluted overnight at 22ÚC in a solution containing 0.1% SDS, 0.5% 2-mercaptoethanol, and 50 mM ammonium bicarbonate, pH 8.0. The extracted protein was precipitated with trichloroacetic acid in the presence of carrier protein (20 µg RNase A) and the pelleted protein was washed with absolute ethanol. When trypsin was used as the digestive agent, the DAT sample was oxidized prior to digestion using performic acid. The final protein sample was resuspended in 50 µl of 50 mM ammonium bicarbonate, pH 8.3 and incubated at 37°C for 5 hours in the presence of 10 µg TPCK-trypsin follow by a second 10 µg dose of TPCK-trypsin and incubation overnight at 37 °C. After digestion, ammonium bicarbonate was removed by repeated lyophilization and peptides were dissolved in 10 µl running buffer (acetic acid 7.8%, formic acid 2.5%, pH 1.9). A 5 µl aliquot of For cyanogen bromide (CNBr) cleavage (22), 32 PO 4 -labeled DAT prepared as above, but without oxidation, was subjected to SDS-PAGE on 8% gels, and electroblotted to a 0.45 µm PVDF membrane. After drying and autoradiography, the region of the membrane containing DAT was excised and feathered by cutting with a razor blade. Immobilized DAT was immersed in 150 µl of 0.25 M CNBr in 70% formic acid. The sample was capped, mixed by vortexing and covered with aluminum foil. The resulting digestion mixture was incubated with agitation at room temperature for 24 h in a chemical fume hood followed by lyophilization and then the addition of 50 µl of purified water and repeated lyophilization. The lyophilized sample was resuspended in 10 µl running buffer (acetic acid 7.8%, formic acid 2.5%, pH 1.9) and subjected to Tris-tricine gel electrophoresis.
RESULTS
Characterization of DAT Phosphorylation in Striatal Slices.
Most of the experiments in this study were performed using striatal slices for metabolic phosphorylation of DAT because they can be labeled for much longer times than synaptosomes, and produce highly radiolabeled DAT suitable for additional analyses. Phosphate incorporation into DAT was easily detectable from slices treated with vehicle only, demonstrating the presence of basal phosphorylation, and the level of phosphorylation increased when the tissue was treated with the PKC activator OAG, the PP1/PP2A inhibitor OA, or OA plus OAG ( To determine which amino acids were phosphorylated under our labeling and stimulation conditions, 32 PO 4 -labeled DAT samples were prepared from striatal slices that were treated with vehicle, OA or OAG. DATs were purified by immunoprecipitation and gel electrophoresis, and subjected to phosphoamino acid analysis on two-dimensional thin-layer plates. The results show that in slices treated individually with vehicle, OA, or OAG, DATs undergo phosphorylation primarily on serine (Fig. 3) , as did tissue treated with OA and OAG together (not shown). A low level of phosphothreonine was consistently observed in all samples, but phosphotyrosine was not detected, even with longer film exposures. We have not attempted to 12 . et al Foster detect phosphotyrosine on DAT by immunoblotting with anti-phosphotyrosine antibodies.
Immunoprecipitation of Trypsin Fragments. Our initial attempts to map phosphorylation sites utilized procedures that have been successful in identifying sites of photoaffinity label attachment (18, 21) . For these experiments 32 PO 4 -labeled DATs prepared from OA/OAG treated slices were proteolyzed with trypsin, which cleaves at lysine and arginine residues, and the digests were immunoprecipitated with antibodies 16 and 18 specific for N-and C-terminal domain epitopes ( and extends through epitope 18 in the C-terminal tail (18, 21) . The 14 kDa fragment (arrow c) is a product of the 45 kDa fragment that retains epitope 16 but terminates in IL1. However, while antisera 16 and 18 immunoprecipitated these photoaffinity labeled fragments and nonproteolyzed 32 PO 4 -labeled DAT (left two lanes), no convincing phosphopeptide fragments were extracted by either of these antisera (middle two lanes), or by antisera 15 and 5 (not shown) that recognize other epitopes in the N-terminal tail and EL2 (18) . This suggested that tryptic proteolysis separated the phosphorylated residues from the antibody epitopes or generated phosphopeptide fragments too small to be analyzed with these techniques. Since the 45 and 32 kDa photoaffinity labeled fragments collectively contain all the transmembrane domains and 13 . et al Foster internal interhelical loops of DAT (18) , the inability to generate comparable 32 PO 4 -labeled fragments is strong evidence that serines 261, 333, 421, 428, and 504 in internal loops 2, 3, 4, and 5 ( Fig. 1) are not major phosphorylation sites.
Immunoprecipitation of Asp-N Fragments. Because these results indicated that the bulk of the 32 PO 4 radiolabeling was occurring on residues in the cytoplasmic tails that were being proteolytically separated from antibody epitopes, we sought to minimize this possibility by digesting DAT with endoproteinase asp-N (asp-N), which cleaves on the N-terminal side of aspartic acid residues. In contrast to the numerous trypsin sites present in these domains, the Nterminal tail of rDAT has no aspartates upstream of epitope 16, while two aspartates in the Cterminal tail are downstream of serines 581 and 585, and most of epitope 18 ( Fig. 1 ). For this experiment membranes prepared from basal and OA/OAG stimulated 32 PO 4 -labeled striatal slices were digested with asp-N, followed by solubilization and immunoprecipitation with antisera 16 or 18. Figure 5 shows that asp-N treatment cleaved a substantial portion (~80%) of the protein and produced strongly labeled phosphopeptide fragments of about 19 and 16 kDa from both basal and stimulated tissue (Fig. 5A, arrow) . Both fragments were immunoprecipitated with serum 16, and precipitation was blocked by inclusion of peptide 16 but not an irrelevant peptide (Fig. 5B) , verifying the presence of epitope 16. These results therefore provide positive identification of the N-terminal cytoplasmic tail of DAT as a major site of both basal and OA/OAG-stimulated phosphorylation.
The masses of the asp-N fragments suggest that they are not generated by proteolysis at D68 or D79 in or near TM1 (Fig. 1) , which would produce fragments of ~7-8 kDa. No fragments of (Fig. 1) . The masses of the 16 and 19 kDa fragments are consistent with cleavage at one or both of these residues or other aspartates in EL2, and the fragments therefore contain the N-terminal tail, TMs 1-3, EL1, IL1 and part of EL2. However, since there are no serines in IL1, the N-terminal tail serines must represent the sites of phosphorylation of these fragments.
Aminopeptidase Analysis. We did not find phosphopeptide fragments in asp-N digestion experiments using C-terminal antibody 18 for immunoprecipitation (not shown). Nevertheless, since some full-length DAT protein remained after asp-N treatment, we could not exclude the possibility that some of the labeled sites were present outside the NH 2 tail. We further investigated this issue by treating 32 PO 4 -labeled gel purified DAT with aminopeptidase (AP) and carboxypeptidase (CP), which non-specifically cleave inward from protein N-or Ctermini. Figure 6A shows that AP treatment removed essentially all 32 Fig. 7C) , are not the major phosphorylation sites, and that most of the 32 PO 4 label is found Nterminal to the epitope. Separation of phosphorylated residues from the epitope could occur by cleavage at one or more of several potential tryptic proteolysis sites present between the first six serines and epitope 16 (Fig. 7C ). This result is also compatible with those shown in Figure 4 One-and Two-Dimensional analysis of Purified DAT Fragments. We have also subjected OA-stimulated phosphorylated DAT to limit digestion with trypsin and cyanogen bromide (CNBr). Extensive proteolysis of immunopurified 32 PO 4 -labeled DAT with trypsin produced three strongly labeled peptide fragments with masses of about 18, 4, and 1.5 kDa, and some less intensely labeled bands (Fig. 8A) . The calculated masses of fragments resulting from complete tryptic proteolysis of the DAT N-terminus (not including mass potentially provided by phosphate incorporation) is shown in Fig. 8C . We do not know if the 1.5 and 4 kDa fragments represent independent or overlapping phosphopeptides generated from digestion at these sites.
Taking into account the limitations of gel electrophoresis for molecular mass estimation, the mass of the smallest fragment is reasonably compatible with various combinations of complete or incomplete digestion of the N-terminus, while the 4 kDa fragment is likely to represent an incomplete digest, for example, a fragment encompassing residues 1-35 or 20-60. The 18 kDa fragment is likely to result from digestion at residues outside the N-terminal tail, and was probably obtained in this experiment but not others because the acid precipitation used during sample preparation denatured the protein in a way that prevented proteolysis at sites that were cleaved in other preparations.
An aliquot of the trypsin digest analyzed in panel A was subjected to two-dimensional thinlayer electrophoresis and chromatography (Fig. 8B) , which produced three intensely labeled spots and some minor spots that correspond to the bands on the Tris/tricine gel. This sample was electrophoresed in the presence of synthetic phosphopeptides corresponding to trypsin fragments from the first five residues of the DAT N-terminus [MS(P)K and S(P)K, where (P) indicates This treatment produced one distinct phosphopeptide of about 12 kDa (Fig. 8A) , a mass that corresponds to cleavage of the DAT Nterminal sequence at residues M106 or M111 in TM2 (Fig. 1) . We did not observe a 32 PO 4 -labeled peptide fragment of ~1 kDa which would correspond to cleavage of DAT at M11 (Fig. 1,   Fig. 8C, arrow) . This result could indicate that serines 2, 4, and 7 are not phosphorylated, consistent with the results of the two-dimensional thin layer analysis of the tryptic fragments, although again, this result would also be obtained if cleavage at M11 did not occur.
DISCUSSION
Although DAT has now been characterized as a phosphorylated protein in several studies, many questions remain regarding its properties and significance. For example, it is not known if The goal of this study was to determine which regions of DAT undergo phosphorylation in brain tissue. For this purpose we characterized DAT phosphorylation in rat striatal slices, finding that phosphate incorporation was stimulated by PKC activators and PP1/PP2A inhibitors as in synaptosomes and cells, and was sufficiently robust for additional sample manipulation.
These preparations were therefore suitable for phosphopeptide mapping analyses with correlation to our previous findings of DAT functional regulation.
For all basal and stimulated conditions we found that DAT is phosphorylated primarily on serine, indicating the potential for these residues to be major determinants of DAT properties 20 . et al Foster regulated by kinases and phosphatases. In addition, a low level of phosphothreonine was consistently observed, and many threonines are found within PKC consensus sequences that are highly conserved throughout the monoamine transporter family (2) . Recent studies have reported the presence of phosphotyrosine on GAT1 and the functional regulation of DAT and GAT1 by tyrosine kinase inhibitors (9, 24, 25) . We found no detectable phosphotyrosine from DATs prepared under the described conditions, but did not employ treatments such as tyrosine kinase activators or phosphotyrosine phosphatase inhibitors specific for generation or preservation of phosphotyrosine.
Several lines of evidence demonstrate that the N-terminal tail of DAT is the major, and possibly sole, domain that undergoes basal, PKC-induced and OA-induced phosphorylation in rat striatum.
Basal and OA/OAG-stimulated 32 PO 4 -labeled asp-N fragments were immunoprecipitated with N-terminal antiserum 16, and aminopeptidase but not carboxypeptidase removed PKC-and/or OA-stimulated 32 PO 4 label from DAT without proteolysis extending past TMs 1-2. In conjunction with the inability to immunoprecipitate tryptic or asp-N phosphorylated fragments with C-terminal antisera, these results indicate that the N-terminus of DAT is the primary site of basal, PKC-stimulated, and OA-stimulated 32 PO 4 incorporation.
In situ proteolysis of the NH 2 tail strongly implicates the region N-terminal to antibody epitope 16 (residues 42-59), as opposed to more internal regions, as the major site of stimulated phosphorylation. The distal end of the NH 2 tail contains six serines, some closely spaced, within 21 . et al Foster the first twenty one residues. The stoichiometry of DAT phosphorylation is unknown, and within this cluster of serines we do not know which combination of sites is utilized. PKC consensus motifs are present at S7 and S21, although it is not known if PKC phosphorylates DAT directly or acts by an indirect mechanism that would lead to phosphorylation at noncanonical sites. We also do not know if phosphorylation induced by PKC activators and phosphatase inhibitors occurs on the same, different, or overlapping sites within this domain.
Limit digestion of phosphorylated DAT with trypsin produced two low molecular weight phosphopeptides, but because of the number of serines, lysines, and arginines in the N-terminal tail we cannot determine if the fragments represent distinct or overlapping peptides. The major endogenous phosphopeptides did not co-migrate with synthetic phosphopeptides representing tryptic digests of the first five rDAT residues containing serines 2 and 4, potential evidence that these sites are not phosphorylated. Digestion with CNBr also failed to generate a phosphorylated fragment consistent with cleavage at M11 that would contain serines 2, 4, and 7. Taken together, all of our results are compatible with phosphorylation of DAT occurring on some combination of serines 12, 13, and 21, but evidence from additional strategies will be required to definitively identify the sites utilized. Our current efforts are directed towards the use of mutagenesis and mass spectrometry to address these questions.
To our knowledge these results are the first to demonstrate phosphorylation of a neurotransmitter transporter on the N-terminal domain. A recent study reported that serine to glycine mutagenesis of residues S262 in IL2, and S586 and T613 in the COOH-tail of human DAT (corresponding to S261, S585, and T612 of rDAT), resulted in the loss of PMA-stimulated phosphorylation (16) . These results directly conflict with our results that positively demonstrate The potential for similarities of our results to phosphorylation sites and PKC dependent regulation of other plasma membrane neurotransmitter transporters is not known. The Nterminal tail of SERT has 7 serines and 10 threonines, some within PKC consensus sites, but phosphorylation site analysis of SERT has not yet been reported. Interestingly, NET, which displays PKC-dependent and independent functional regulation (26), has three threonines but no serines in its N-terminal domain. Our results differ from the phosphorylation pattern found for synaptic vesicle acetylcholine and monoamine transporters, which undergo phosphorylation exclusively on C-terminal tail residues (27, 28) . In the case of the VAChT, mutation of serine 480 resulted in altered intracellular sorting that may impact neurotransmitter packaging (29).
This difference in phosphorylation patterns of plasma membrane and vesicular neurotransmitter transporters may indicate the potential for these classes of proteins to be subject to different At present, the function of DAT phosphorylation is not known. A correlation exists between the dose and kinetics of PKC-and OA-induced DAT phosphorylation, down-regulation, and transporter internalization (5, (10) (11) (12) (13) 33) . Transporter phosphorylation could serve as a marker for recruitment of endocytic adaptor proteins in a manner analogous to that of G protein coupled receptors (34) . Other potential functions of phosphorylation could include recognition by other targeting proteins or involvement in an autoregulatory mechanism. For example, the N-terminus of GAT1 interacts with the SNARE protein syntaxin 1 in a PKC-specific manner that results in regulation of GABA transport (35) (36) (37) , although it is not known if this is mediated by GAT1 phosphorylation. Recent evidence also indicates the potential for DAT and SERT to exist as dimers or oligomers (38, 39) , a process controlled for some proteins by phosphorylation (40) .
Our current efforts are aimed at mutating N-terminal DAT serines to assess their usage as phosphorylation sites and examine their involvement in down-regulation and other processes. 
